1. Proteomic biomarkers in body fluids associated with pancreatic cancer
   Cristina Jimenez-Luna et al, 2018, Oncotarget CrossRef
2. Blood biomarkers for differential diagnosis and early detection of pancreatic cancer
   Fawaz N. Al-Shaheri et al, 2021, Cancer Treatment Reviews CrossRef
3. The value of macrophage inhibitory cytokine‐1 level in differentiating benign from malignant solitary pulmonary nodules
   Chun Hua Xu et al, 2018, The Clinical Respiratory Journal CrossRef
4. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
   Robert S O'Neill et al, 2021, World Journal of Gastroenterology CrossRef
5. Plasma inflammatory cytokines and survival of pancreatic cancer patients
   A. Babic et al, 2018, Clinical and Translational Gastroenterology CrossRef
6. Growth differentiation factor-15 may be a novel biomarker in pancreatic cancer: A review
   Meng Guo et al, 2024, Medicine CrossRef
7. High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers
   Thilde Terkelsen et al, 2021, Molecular Oncology CrossRef
8. Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer
   Ryan Clay et al, 2019, Theranostic Approach for Pancreatic Cancer CrossRef
9. Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis—A Literature Review
   Valborg Vang Poulsen et al, 2024, Biomolecules CrossRef
10. Perspectives in the treatment of pancreatic adenocarcinoma
    Angel Cid-Arregui, 2015, World Journal of Gastroenterology CrossRef
11. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma
    Guo-Tian Ruan et al, 2021, Aging CrossRef
12. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19–9 as a biomarker for diagnosis of pancreatic cancer
    Ying Yang et al, 2018, Medicine CrossRef
13. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry
    Che‐Yi Chou et al, 2020, Rapid Communications in Mass Spectrometry CrossRef
14. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review
    Natalia Calanzani et al, 2021, Advances in Therapy CrossRef
15. Serum macrophage inhibitory cytokine‐1 as a clinical marker for non–small cell lung cancer
    Chunhua Xu et al, 2021, Journal of Cellular and Molecular Medicine CrossRef